Ongoing Trials

January 5, 2023

Ongoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancer

This trial is seeking to find out whether patients with the PD-L1 biomarker can either delay having chemotherapy or avoid it altogether
September 26, 2022

Ongoing Trials: A closer look at ECOG-ACRIN’s studies for patients with head and neck cancer

These five clinical trials are exploring possible new treatments for adults with head and neck cancers. These cancers can involve the mouth, throat, voice box (larynx)—or, much more rarely, the nose/sinuses or saliva glands